Ocular Therapeutix (OCUL) Share-based Compensation (IS) (2024 - 2026)
Ocular Therapeutix (OCUL) reported Share-based Compensation (IS) of $14.65 million for Q2 2026, up 51.4% from $9.68 million a year earlier but down 6.0% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ocular Therapeutix's Share-based Compensation (IS) came in at $53.28 million, up 56.8% year-over-year; for FY2025, it was $43.18 million, up 30.4% from FY2024.
- By year, Share-based Compensation (IS) came in at $33.11 million in FY2024 (+85.7%) and $17.83 million in FY2023.
- Five-year quarterly Share-based Compensation (IS) spans a low of $6.64 million in Q3 2024 and a high of $15.58 million in Q1 2026.
- Year over year, Share-based Compensation (IS) has now increased in each of the last four quarters, with growth averaging 41.8% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $15.58 million (Q1 2026), $11.36 million (Q4 2025) and $11.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.08 Bn | 1,101.67 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 616.40 Bn | 534.93 Bn | 17.26 Bn | - |
| 3 | AbbVie | 501.19 Bn | 474.31 Bn | 12.70 Bn | - |
| 4 | Merck | 367.18 Bn | 321.56 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.67 Bn | 235.36 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.57 Bn | 190.97 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.62 Bn | 164.82 Bn | 6.22 Bn | - |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn | - |
| 10 | Ocular Therapeutix | 1.45 Bn | -899.60 Mn | 11.46 Mn | 14.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.65 Mn |
| Mar 31, 2026 | 15.58 Mn |
| Dec 31, 2025 | 11.36 Mn |
| Sep 30, 2025 | 11.69 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Mar 31, 2025 | 10.46 Mn |
| Dec 31, 2024 | 7.20 Mn |
| Sep 30, 2024 | 6.64 Mn |
| Jun 30, 2024 | 11.29 Mn |
| Mar 31, 2024 | 7.98 Mn |
API Access
Ocular Therapeutix Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();